A Phase III, Open-label, Randomised, Multicentre Study to Evaluate AZD0120 in Participants With Relapsed Refractory Multiple Myeloma.

by palligoelme@gmail.com | Feb 6, 2026 | Clinical Trials

​ Conditions: Relapsed Refractory Multiple Myeloma Interventions: Biological: AZD0120; Drug: Daratumumab; Drug: Carfilzomib; Drug: Dexamethasone; Drug: Bortezomib; Drug: Pomalidomide Sponsors: AstraZeneca Not yet recruiting Conditions: Relapsed Refractory Multiple...

Prospective Research on the Intervention of Myoless2.0 in Europe (PRIME)

by palligoelme@gmail.com | Feb 6, 2026 | Clinical Trials

​ Conditions: Myopia Progression Interventions: Other: myopia control lens Sponsors: Indizen Optical Technologies, S.L.U.; Hospital San Carlos, Madrid; University of Minho; University of Ulster Not yet recruiting Conditions: Myopia Progression Interventions: Other:...

Neo-Adjuvant Endocrine Therapy in Post-Menopausal Hormone Receptor Positive HER 2 Neu Negative Node Positive Early-Stage Breast Cancer Patients With One Year of Letrozole.

by palligoelme@gmail.com | Feb 6, 2026 | Clinical Trials

​ Conditions: Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer Interventions: Drug: Letrozole Sponsors: Cancer Care Hospital & Research Centre Foundation, Lahore Not yet recruiting Conditions: Hormone Receptor-Positive, HER2-Negative, Node...

Age Related Chromatin Remodelling as a Therapeutic Target for Organ Protection in Cardiac Surgery

by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials

​ Conditions: Cardiac Surgery; Organ Protection; Ageing Interventions: Other: other Sponsors: University of Leicester Active, not recruiting Conditions: Cardiac Surgery; Organ Protection; Ageing Interventions: Other: other Sponsors: University of Leicester Active, not...

A Multicenter Trial of YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials

​ Conditions: Extensive-stage Small Cell Lung Cancer (SCLC) Interventions: Drug: Yishen Qutong Granules; Drug: Yishen Qutong Simulant Granules Sponsors: LI FENG; Henan Cancer Hospital; Fudan University; Shanxi Province Cancer Hospital Enrolling by...